Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Identification of Novel Biomarkers Is Required to Improve Adult SMA Patient Stratification, Diagnosis and Treatment
Piera Smeriglio, Paul Langard, Giorgia Querin, et al.
Journal of Personalized Medicine (2020) Vol. 10, Iss. 3, pp. 75-75
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

The impact of three SMN2 gene copies on clinical characteristics and effect of disease-modifying treatment in patients with spinal muscular atrophy: a systematic literature review
Claudia Dosi, Riccardo Masson
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 9
Serum creatine kinase and creatinine in adult spinal muscular atrophy under nusinersen treatment
Maren Freigang, Claudia D. Wurster, Tim Hagenacker, et al.
Annals of Clinical and Translational Neurology (2021) Vol. 8, Iss. 5, pp. 1049-1063
Open Access | Times Cited: 47
Identifying Biomarkers of Spinal Muscular Atrophy for Further Development
Jacqueline Glascock, Basil T. Darras, Thomas O. Crawford, et al.
Journal of Neuromuscular Diseases (2023) Vol. 10, Iss. 5, pp. 937-954
Open Access | Times Cited: 16
Alteration of LARGE1 abundance in patients and a mouse model of 5q-associated spinal muscular atrophy
Andreas Roos, Linda-Isabell Schmitt, Christina Hansmann, et al.
Acta Neuropathologica (2024) Vol. 147, Iss. 1
Open Access | Times Cited: 5
Artificial intelligence-driven phenotyping of zebrafish psychoactive drug responses
Dmitrii V. Bozhko, Vladislav Myrov, Sofia M. Kolchanova, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2021) Vol. 112, pp. 110405-110405
Closed Access | Times Cited: 29
Assessment of Health-Related Quality of Life in Adult Spinal Muscular Atrophy Under Nusinersen Treatment—A Pilot Study
Andreas Thimm, Svenja Brakemeier, Kathrin Kizina, et al.
Frontiers in Neurology (2022) Vol. 12
Open Access | Times Cited: 20
MiR34 contributes to spinal muscular atrophy and AAV9-mediated delivery of MiR34a ameliorates the motor deficits in SMA mice
Tai‐Heng Chen, Shih-Hsin Chang, Yu-Fu Wu, et al.
Molecular Therapy — Nucleic Acids (2023) Vol. 32, pp. 144-160
Open Access | Times Cited: 11
Program with last minute abstracts of the Padua Days on Muscle and Mobility Medicine, 27 February – 2 March, 2024 (2024Pdm3)
Sandra Zampieri, Ines Bersch, Piera Smeriglio, et al.
European Journal of Translational Myology (2024)
Open Access | Times Cited: 4
Neurofilament Levels in CSF and Serum in an Adult SMA Cohort Treated with Nusinersen
Kelly Rich, Ashley Fox, Mehmet E. Yalvaç, et al.
Journal of Neuromuscular Diseases (2021) Vol. 9, Iss. 1, pp. 111-119
Closed Access | Times Cited: 25
Spinal Muscular Atrophy after Nusinersen Therapy: Improved Physiology in Pediatric Patients with No Significant Change in Urine, Serum, and Liquor 1H-NMR Metabolomes in Comparison to an Age-Matched, Healthy Cohort
Leon Deutsch, Damjan Osredkar, Janez Plavec, et al.
Metabolites (2021) Vol. 11, Iss. 4, pp. 206-206
Open Access | Times Cited: 24
Cathepsin D as biomarker in cerebrospinal fluid of nusinersen‐treated patients with spinal muscular atrophy
David Schorling, Heike Kölbel, Andreas Hentschel, et al.
European Journal of Neurology (2022) Vol. 29, Iss. 7, pp. 2084-2096
Open Access | Times Cited: 19
Orthopedic Manifestations of Spinal Muscular Atrophy: Clarified and Unresolved Theoretical and Practical Issues
A.М. Zyma, Yu.M. Huk, A.V. Smaha, et al.
TERRA ORTHOPAEDICA (2025), Iss. 4(123), pp. 32-38
Closed Access
Magnetic resonance reveals mitochondrial dysfunction and muscle remodelling in spinal muscular atrophy
Laura E. Habets, Bart Bartels, Fay‐Lynn Asselman, et al.
Brain (2021) Vol. 145, Iss. 4, pp. 1422-1435
Open Access | Times Cited: 21
Childhood spinal muscular atrophy
David S. Younger, Jerry R. Mendell
Handbook of clinical neurology (2023), pp. 43-58
Closed Access | Times Cited: 9
NAIP Gene Deletion and SMN2 Copy Number as Molecular Tools in Predicting the Severity of Spinal Muscular Atrophy
Abdel Nasser H Abd El Mutaleb, Fawziya A. R. Ibrahim, Fayed Attia Koutb Megahed, et al.
Biochemical Genetics (2024) Vol. 62, Iss. 6, pp. 5051-5072
Open Access | Times Cited: 3
Insights into spinal muscular atrophy from molecular biomarkers
Xiaodong Xing, Xinzhu Liu, Xiandeng Li, et al.
Neural Regeneration Research (2024) Vol. 20, Iss. 7, pp. 1849-1863
Open Access | Times Cited: 3
Role of circulating biomarkers in spinal muscular atrophy: insights from a new treatment era
Giorgia Querin, M. Gómez García de la Banda, Piera Smeriglio
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 8
Increased chitotriosidase 1 concentration following nusinersen treatment in spinal muscular atrophy
Maren Freigang, Petra Steinacker, Claudia D. Wurster, et al.
Orphanet Journal of Rare Diseases (2021) Vol. 16, Iss. 1
Open Access | Times Cited: 17
Association among biomarkers, phenotypes, and motor milestones in Chinese patients with 5q spinal muscular atrophy types 1–3
Shijia Ouyang, Xiaoyin Peng, Wen‐Chen Huang, et al.
Frontiers in Neurology (2024) Vol. 15
Open Access | Times Cited: 2
Integrative network analysis interweaves the missing links in cardiomyopathy diseasome
Pankaj Kumar Chauhan, Ramanathan Sowdhamini
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 11
Enhanced low-threshold motor unit capacity during endurance tasks in patients with spinal muscular atrophy using pyridostigmine
Laura E. Habets, Bart Bartels, Jeroen A. L. Jeneson, et al.
Clinical Neurophysiology (2023) Vol. 154, pp. 100-106
Open Access | Times Cited: 6
Corneal confocal microscopy reveals small nerve fibre loss correlating with motor function in adult spinal muscular atrophy
Andreas Thimm, Svenja Brakemeier, Merve Dag, et al.
European Journal of Neurology (2023) Vol. 30, Iss. 9, pp. 2821-2827
Open Access | Times Cited: 5
Characterization of SMA Type II Skeletal Muscle from Treated Patients shows Mitochondrial Deficiency and Denervation
Fiorella C. Grandi, Stéphanie Astord, Sonia Pezet, et al.
JCI Insight (2024) Vol. 9, Iss. 20
Open Access | Times Cited: 1
The Potential of Induced Pluripotent Stem Cells to Test Gene Therapy Approaches for Neuromuscular and Motor Neuron Disorders
M Cappella, Sahar Elouej, Maria Grazia Biferi
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 8
Advances in the Therapy of Spinal Muscular Atrophy
Jenna Klotz, Carolina Tesi Rocha, Sally Dunaway Young, et al.
The Journal of Pediatrics (2021) Vol. 236, pp. 13-20.e1
Closed Access | Times Cited: 8
Page 1 - Next Page

Scroll to top